Skip to search formSkip to main contentSkip to account menu

Stem Cell Mobilization Therapy

Known as: Mobilization Therapy 
Therapy to cause release of stem cells from the bone marrow into the peripheral blood circulation for the purpose of collection.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Ischemic compression and joint mobilisation for the treatment of nonspecific myofascial foot pain: findings from two quasi-experimental before-and-after studies.
OBJECTIVE The aim of this study was to evaluate the efficacy of myofascial therapy involving ischemic compression on trigger… 
Review
2012
Review
2012
Who should be really considered as a poor mobilizer in the plerixafor era?
2007
2007
Enhanced mobilization of bone marrow cells does not ameliorate renal fibrosis.
BACKGROUND The plasticity of bone marrow-derived stem cells, also comprising haematopoietic stem cells, has been shown to extend… 
2006
2006
Pre-mobilization therapy blood CD34+ cell count predicts the likelihood of successful hematopoietic stem cell mobilization
We examined pre-mobilization blood CD34+ cell count to predict ability to mobilize adequate peripheral blood progenitor cells… 
2002
2002
Matrix metalloproteinase‐9 (gelatinase B) is elevated during mobilization of peripheral blood progenitor cells by G–CSF
BACKGROUND: Matrix metalloproteinase‐9 (MMP‐9 or gelatinase B) has recently been implicated in the IL‐8‐induced mobilization of… 
2002
2002
Breast cancer cell contamination of blood stem cell products in patients with metastatic breast cancer: predictors and clinical relevance.
The incidence and clinical relevance of tumor cells contaminating the stem cell products of patients with advanced breast cancer… 
1999
1999
Monitoring of CD34+ cells during leukapheresis allows a single, successful collection of hemopoietic progenitors in patients with low numbers of circulating stem cells
We have studied a total of 188 patients with hematological malignancies, submitted to mobilization therapy with G-CSF associated… 
Highly Cited
1998
Highly Cited
1998
CD34+CD33- cells influence days to engraftment and transfusion requirements in autologous blood stem-cell recipients.
PURPOSE To evaluate the reliability of CD34/CD33 subset enumeration as a predictor of hematopoietic repopulating potential in… 
1998
1998
Chemotherapy-induced mobilization of karyotypically normal PBSC for autografting in CML
High-dose chemotherapy with autologous transplantation of in vivo purged PBSC is a new and interesting therapeutic option for CML… 
1998
1998
Factors which affect the CFU‐GM content of the peripheral blood haemopoietic progenitor cell harvests in patients with acute myeloid leukaemia
Autologous peripheral blood haemopoietic stem cells (PBSC) were harvested from 30 patients with de novo acute leukaemia, 29 of… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)